VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
2452
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
441
Interactions with Platform & by Email
PARTICIPANTS
74
Unique # Participated
VALIDATIONS
33
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
114
PAGES
186
EDITION
6
PRICE
USD $4950
Easy Growth Opportunities Often Go Unnoticed. Find Your "Low Hanging Fruit".
Top Markets for Inhalation and Nasal Spray Generic Drugs.
Amid the COVID-19 crisis, the global market for Inhalation and Nasal Spray Generic Drugs estimated at US$26.6 Billion in the year 2020, is projected to reach a revised size of US$38 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027.Corticosteroids, one of the segments analyzed in the report, is projected to grow at a 5.1% CAGR to reach US$9.3 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bronchodilator segment is readjusted to a revised 5.3% CAGR for the next 7-year period. This segment currently accounts for a 21.9% share of the global Inhalation and Nasal Spray Generic Drugs market.
The Inhalation and Nasal Spray Generic Drugs market in the U.S. is estimated at US$7.9 Billion in the year 2020. The country currently accounts for a 29.48% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$6.7 Billion in the year 2027 trailing a CAGR of 5% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR while Rest of European market (as defined in the study) will reach US$6.7 Billion by the year 2027.
In the global Antihistamines segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2 Billion in the year 2020 will reach a projected size of US$2.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.3 Billion by the year 2027.We bring years of research experience to this 6th edition of our report. The 186-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Allergan PLC; Cipla Ltd.; Mylan NV; Nephron Pharmaceuticals Corporation
» Application (Asthma, COPD, Allergic Rhinitis, Other Applications) » Drug Class (Corticosteroids, Bronchodilator, Antihistamines, Combinations, Decongestant Sprays)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Inhalation and Nasal Spray Generic Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Inhalation and Nasal Spray Generic Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Inhalation and Nasal Spray Generic Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Asthma (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025 |
| Asthma (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017 |
| Asthma (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| COPD (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| COPD (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| COPD (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Allergic Rhinitis (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025 |
| Allergic Rhinitis (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017 |
| Allergic Rhinitis (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 |
| Other Applications (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 |
| Other Applications (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 |
| Other Applications (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Corticosteroids (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Corticosteroids (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Corticosteroids (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Bronchodilator (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Bronchodilator (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Bronchodilator (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Antihistamines (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Antihistamines (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Antihistamines (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Combinations (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
| Combinations (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Combinations (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Decongestant Sprays (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Decongestant Sprays (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Decongestant Sprays (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Inhalation and Nasal Spray Generic Drugs Market Share (in %) by Company: 2019 & 2025 |
| United States Inhalation and Nasal Spray Generic Drugs Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Inhalation and Nasal Spray Generic Drugs Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 |
| Inhalation and Nasal Spray Generic Drugs Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| United States Inhalation and Nasal Spray Generic Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025 |
| Inhalation and Nasal Spray Generic Drugs Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017 |
| United States Inhalation and Nasal Spray Generic Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Inhalation and Nasal Spray Generic Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Canadian Inhalation and Nasal Spray Generic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Canadian Inhalation and Nasal Spray Generic Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025 |
| Canadian Inhalation and Nasal Spray Generic Drugs Historic Market Review by Drug Class in US$ Million: 2009-2017 |
| Inhalation and Nasal Spray Generic Drugs Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025 |
| JAPAN |
| Japanese Demand Estimates and Forecasts for Inhalation and Nasal Spray Generic Drugs in US$ Million by Application: 2018 to 2025 |
| Japanese Inhalation and Nasal Spray Generic Drugs Market in US$ Million by Application: 2009-2017 |
| Inhalation and Nasal Spray Generic Drugs Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| Japanese Market for Inhalation and Nasal Spray Generic Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017 |
| Japanese Inhalation and Nasal Spray Generic Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Demand for Inhalation and Nasal Spray Generic Drugs in US$ Million by Application: 2018 to 2025 |
| Inhalation and Nasal Spray Generic Drugs Market Review in China in US$ Million by Application: 2009-2017 |
| Chinese Inhalation and Nasal Spray Generic Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Chinese Inhalation and Nasal Spray Generic Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017 |
| Chinese Inhalation and Nasal Spray Generic Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| EUROPE |
| Market Facts & Figures |
| European Inhalation and Nasal Spray Generic Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Inhalation and Nasal Spray Generic Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Inhalation and Nasal Spray Generic Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Inhalation and Nasal Spray Generic Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| European Inhalation and Nasal Spray Generic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| European Inhalation and Nasal Spray Generic Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017 |
| European Inhalation and Nasal Spray Generic Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| FRANCE |
| Inhalation and Nasal Spray Generic Drugs Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 |
| French Inhalation and Nasal Spray Generic Drugs Historic Market Review in US$ Million by Application: 2009-2017 |
| French Inhalation and Nasal Spray Generic Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Inhalation and Nasal Spray Generic Drugs Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Inhalation and Nasal Spray Generic Drugs Historic Market Scenario in US$ Million by Drug Class: 2009-2017 |
| French Inhalation and Nasal Spray Generic Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| GERMANY |
| Inhalation and Nasal Spray Generic Drugs Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| German Inhalation and Nasal Spray Generic Drugs Market in Retrospect in US$ Million by Application: 2009-2017 |
| Inhalation and Nasal Spray Generic Drugs Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025 |
| German Inhalation and Nasal Spray Generic Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017 |
| German Inhalation and Nasal Spray Generic Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Demand for Inhalation and Nasal Spray Generic Drugs in US$ Million by Application: 2018 to 2025 |
| Inhalation and Nasal Spray Generic Drugs Market Review in Italy in US$ Million by Application: 2009-2017 |
| Italian Inhalation and Nasal Spray Generic Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Italian Inhalation and Nasal Spray Generic Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017 |
| Italian Inhalation and Nasal Spray Generic Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED KINGDOM |
| United Kingdom Demand Estimates and Forecasts for Inhalation and Nasal Spray Generic Drugs in US$ Million by Application: 2018 to 2025 |
| United Kingdom Inhalation and Nasal Spray Generic Drugs Market in US$ Million by Application: 2009-2017 |
| Inhalation and Nasal Spray Generic Drugs Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Inhalation and Nasal Spray Generic Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017 |
| United Kingdom Inhalation and Nasal Spray Generic Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Inhalation and Nasal Spray Generic Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Rest of Europe Inhalation and Nasal Spray Generic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe Inhalation and Nasal Spray Generic Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017 |
| Rest of Europe Inhalation and Nasal Spray Generic Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Inhalation and Nasal Spray Generic Drugs Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 |
| Asia-Pacific Inhalation and Nasal Spray Generic Drugs Historic Market Review in US$ Million by Application: 2009-2017 |
| Asia-Pacific Inhalation and Nasal Spray Generic Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Inhalation and Nasal Spray Generic Drugs Historic Market Scenario in US$ Million by Drug Class: 2009-2017 |
| Asia-Pacific Inhalation and Nasal Spray Generic Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025 |
| REST OF WORLD |
| Rest of World Inhalation and Nasal Spray Generic Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Inhalation and Nasal Spray Generic Drugs Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Rest of World Inhalation and Nasal Spray Generic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Rest of World Inhalation and Nasal Spray Generic Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025 |
| Rest of World Inhalation and Nasal Spray Generic Drugs Historic Market Review by Drug Class in US$ Million: 2009-2017 |
| Inhalation and Nasal Spray Generic Drugs Market in Rest of World: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 4 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com